Publicaciones en las que colabora con Vanessa Roldan Schilling (17)

2016

  1. Repercusiones en la posología de los anticoagulantes orales no antagonistas de la vitamina K por las variaciones de la función renal de los pacientes con fibrilación auricular e insuficiencia cardiaca aguda reciente

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 134-140

2015

  1. Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 68, Núm. 6, pp. 497-504

  2. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation

    European Journal of Clinical Investigation, Vol. 45, Núm. 9, pp. 899-905

2014

  1. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation

    Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 781-788

  2. Usefulness of N- Terminal pro-B- Type natriuretic peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation

    Stroke, Vol. 45, Núm. 3, pp. 696-701

2013

  1. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

    Thrombosis and Haemostasis, Vol. 109, Núm. 5, pp. 956-960

  2. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Age and Ageing, Vol. 42, Núm. 1, pp. 70-75

  3. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy

    Chest, Vol. 143, Núm. 1, pp. 179-184

  4. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding)

    American Journal of Cardiology, Vol. 111, Núm. 8, pp. 1159-1164

  5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation

    Journal of the American College of Cardiology, Vol. 62, Núm. 23, pp. 2199-2204

  6. The prognostic role of the adiponectin levels in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 43, Núm. 2, pp. 168-173

  7. β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment

    Chest, Vol. 144, Núm. 5, pp. 1564-1570

2012

  1. Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

    European Journal of Clinical Investigation, Vol. 42, Núm. 12, pp. 1302-1308

  2. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

    Journal of Thrombosis and Haemostasis, Vol. 10, Núm. 8, pp. 1500-1507

  3. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

    Circulation: Cardiovascular Interventions, Vol. 5, Núm. 4, pp. 459-466

2011

  1. An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization

    Chest, Vol. 139, Núm. 6, pp. 1402-1409

2009

  1. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

    European Heart Journal, Vol. 30, Núm. 8, pp. 932-939